Tyra Biosciences (TYRA) Research & Development (2020 - 2026)
Tyra Biosciences (TYRA) posted Research & Development of $33.5 million for Q1 2026, up 18.75% on a QoQ basis from $28.2 million in Q4 2025, and up 34.07% year-over-year from $25.0 million in Q1 2025.
Tyra Biosciences (TYRA) Research & Development (2020 - 2026) Analysis & Trends
Tyra Biosciences' Research & Development history runs 7 years deep, the most recent figure standing at $33.5 million for Q1 2026.
- Quarterly Research & Development rose 34.07% year-over-year to $33.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.4 million (up 26.86% YoY) and the FY2025 annual result came in at $102.9 million, up 28.54% from the prior year.
- Research & Development was $33.5 million for Q1 2026 at Tyra Biosciences, up from $28.2 million in the prior quarter.
- Across five years, Research & Development topped out at $33.5 million in Q1 2026 and bottomed at $9.6 million in Q1 2022.
- A 5-year average of $18.9 million and a median of $19.3 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 174.98% — and 2023, when it rose 0.95%.
- Tyra Biosciences' Research & Development stood at $10.4 million in 2022, then surged by 98.82% to $20.7 million in 2023, then advanced by 7.27% to $22.2 million in 2024, then gained by 27.08% to $28.2 million in 2025, then climbed by 18.75% to $33.5 million in 2026.
- Business Quant data shows TYRA's Research & Development at $33.5 million in Q1 2026, $28.2 million in Q4 2025, and $25.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | 33.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.47 Mn |
| Dec 31, 2025 | 28.19 Mn |
| Sep 30, 2025 | 25.47 Mn |
| Jun 30, 2025 | 24.31 Mn |
| Mar 31, 2025 | 24.96 Mn |
| Dec 31, 2024 | 22.18 Mn |
| Sep 30, 2024 | 22.70 Mn |
| Jun 30, 2024 | 18.00 Mn |
| Mar 31, 2024 | 17.20 Mn |
| Dec 31, 2023 | 20.68 Mn |
| Sep 30, 2023 | 19.27 Mn |
| Jun 30, 2023 | 12.16 Mn |
| Mar 31, 2023 | 10.41 Mn |
| Dec 31, 2022 | 10.40 Mn |
| Sep 30, 2022 | 10.92 Mn |
| Jun 30, 2022 | 12.05 Mn |
| Mar 31, 2022 | 9.65 Mn |
| Dec 31, 2021 | 7.25 Mn |
| Sep 30, 2021 | 5.48 Mn |
| Jun 30, 2021 | 4.38 Mn |